GliaSite radiation therapy system regulatory update

FDA granted 510(k) clearance to the GliaSite radiation therapy system for use with Iotrex to treat brain cancer. Marketing partner IsoRay Inc. (NYSE-A:ISR, Richland, Wash.) plans to launch GliaSite, ...